<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>A summary of available tests for HEV infection</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Test name</th>
    <th>Time from infection to positive</th>
    <th>Duration of clinical usefulness</th>
    <th>Sensitivity</th>
    <th>Specificity</th>
    <th>Comments</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Anti-HEV IgM</td>
    <td>~ 4 weeks</td>
    <td>6–9 months</td>
    <td>
     <p>Immunocompromised:85–87.5%</p>
     <p>Immunocompetent: 80–90%</p>
    </td>
    <td>≥ 99.5%</td>
    <td>Usually first test to be considered</td>
   </tr>
   <tr>
    <td>Anti-HEV IgG</td>
    <td>~ 4 weeks</td>
    <td>years</td>
    <td>
     <p>Immunocompromised:15–45%</p>
     <p>Immunocompetent: 80–90%</p>
    </td>
    <td>89–98%</td>
    <td>Useful for seroepidemiological studies; not clinically useful</td>
   </tr>
   <tr>
    <td>HEV Capsid antigen</td>
    <td>~ 2 weeks</td>
    <td>4–5 weeks</td>
    <td>88–99%</td>
    <td>100%</td>
    <td>Low cost and easy to perform; can be considered for blood screening</td>
   </tr>
   <tr>
    <td>HEV RNA</td>
    <td>~ 2 weeks</td>
    <td>4–5 weeks</td>
    <td>–</td>
    <td>–</td>
    <td>Gold standard test; useful in immunocompromised and seronegative patients</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
